Inventor · disambiguated record
Jeffrey Mckenna
Also filed as: MCKENNA JEFFREY · MCKENNA JEFFREY M · MCKENNA JEFFREY MARK
17 granted patents·11 pending applications·126 citations·filing 1999–2024
91Inventor score
Top patents by PatentIndex Score
28 records- 0195US8383634B2Methods of treatment using heteroaryl compounds and compositions thereofSIGNAL PHARM LLC·Filed 2011·Granted Feb 26, 2013·46 cites·4 claims
- 0295US7968556B2Heteroaryl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2007·Granted Jun 28, 2011·41 cites·3 claims
- 0384US10906930B2Compositions and methods for activating “stimulator of interferon gene”-dependent signallingADURO BIOTECH INC·Filed 2016·Granted Feb 2, 2021·3 cites·12 claims
- 0477US8546416B23-spirocyclic piperidine derivatives as ghrelin receptor agonistsAMBARKHANE AMEET VIJAY·Filed 2012·Granted Oct 1, 2013·8 cites·11 claims
- 0574US12129246B1Hydroquinazoline derivatives for the treatment of a disease or disorderNOVARTIS AG·Filed 2024·Granted Oct 29, 2024·0 cites·30 claims
- 0674US7037936B2Compounds useful for the treatment of cancer, compositions thereof and methods therewithSIGNAL PHARM LLC·Filed 2003·Granted May 2, 2006·8 cites·2 claims
- 0772US12161648B2Covalent targeting of E3 ligasesUNIV CALIFORNIA·Filed 2019·Granted Dec 10, 2024·1 cites·13 claims
- 0868US9763957B2Autotaxin inhibitorsNOVARTIS AG·Filed 2014·Granted Sep 19, 2017·1 cites·7 claims
- 0967US7994203B2Organic compoundsNOVARTIS AG·Filed 2009·Granted Aug 9, 2011·1 cites·10 claims
- 1066US2025120982A1Covalent targeting of e3 ligasesUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1162US6989395B2Imidazolyl-cyclic acetalsAVENTIS PHARMA LTD·Filed 2003·Granted Jan 24, 2006·1 cites·27 claims
- 1262US2025206708A1An oxaziridine platform for targeting functional allosteric methionine sitesNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1360US8163785B2Pyrazolo[5,1b]oxazole derivatives as CRF-1 receptor antagonistsDEVEREUX NICHOLAS JAMES·Filed 2011·Granted Apr 24, 2012·1 cites·11 claims
- 1459US10975114B2Bis 2′-5′-RR-(3′F-A)(3′F-A) cyclic dinucleotide compound and uses thereofADURO BIOTECH INC·Filed 2018·Granted Apr 13, 2021·0 cites·17 claims
- 1559US6602877B1Imidazolyl-cyclic acetalsAVENTIS PHARMA LTD·Filed 1999·Granted Aug 5, 2003·15 cites·36 claims
- 1652US2009270418A1Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewithSLOSS MARIANNE·Filed 2009·Application pending·0 cites
- 1750US2006142352A1Compounds useful for the treatment of cancer, compositions thereof and methods therewithUNIV NEW YORK·Filed 2006·Application pending·0 cites
- 1850US2024252655A1Deubiquitinase-targeting chimeras and related methodsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1950US2022211815A1Combination therapy for the treatment of cancerNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2046US10183025B2Autotaxin inhibitorsNOVARTIS AG·Filed 2017·Granted Jan 22, 2019·0 cites·5 claims
- 2144US2008004271A1Inhibitors of TNFalpha, PDE4 and B-RAF, compositions thereof and methods of use therewithMCKENNA JEFFREY M·Filed 2007·Application pending·0 cites
- 2244US2016168119A1Autotaxin inhibitorsBAETTIG URS·Filed 2014·Application pending·0 cites
- 2342US2013331369A13-Spirocyclic Piperidine Derivatives as Ghrelin Receptor AgonistsAMBARKHANE AMEET VIJAY·Filed 2013·Application pending·0 cites
- 2437US11098077B2Locked nucleic acid cyclic dinucleotide compounds and uses thereofCHINOOK THERAPEUTICS INC·Filed 2017·Granted Aug 24, 2021·0 cites·20 claims
- 2536US2012295942A1Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor AntagonistsDEVEREUX NICHOLAS JAMES·Filed 2011·Application pending·0 cites
- 2634US2011201629A1Cyclohexyl amide derivatives as crf receptor antagonistsATKINSON BENJAMIN·Filed 2011·Application pending·0 cites
- 2730US9359381B2Tricyclic compounds for inhibiting the CFTR channelAHMED MAHBUB·Filed 2013·Granted Jun 7, 2016·0 cites·23 claims
- 2829US9303035B2Substituted pyrazino[1′,2′:1,2]pyrrolo[3,4-d]pyrimidines, pyrimido[4′,5′:3,4]pyrrolo[2,1-c][1,4]oxazines and pyrimido[4′,5′:3,4]pyrrolo[1,2-d][1,4]oxazepines for inhibiting the CFTR channelAHMED MAHBUB·Filed 2013·Granted Apr 5, 2016·0 cites·22 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →